SBI Healthcare Opportunities Fund - Dividend - Regular Plan

  • Previous Nav

  • Net Change on 28-01-2020

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Dividend | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN - DIVIDEND 5.89 10.59 3.49 -1.81 0.17 14.51
S&P BSE Health Care 6.66 10.21 2.59 -1.51 -1.66 13.51
S&P BSE Health Care - TRI 6.66 10.25 3.39 -0.87 -1.08 12.14
S&P BSE SENSEX - TRI -0.99 4.88 15.53 15.25 8.23 13.20

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN - DIVIDEND Jul 03, 1999 3.49 -1.81 0.17 2.40 926.47
Nippon India Pharma Fund-Dividend-Dividend Jun 05, 2004 3.55 5.70 3.88 2.07 2,416.99
UTI Healthcare Fund - Regular Plan - Income Option Aug 25, 1999 5.87 1.05 0.11 2.36 394.61

Fund Holdings as on 31-December-2019

  • Sun Pharmaceutical Industries Ltd.

  • Divi's Laboratories Ltd.

  • Cipla Ltd.

  • Lupin Ltd.

  • Abbott India Ltd.

  • Alkem Laboratories Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Alembic Pharmaceuticals Ltd.

  • Strides Pharma Science Ltd.

  • Ajanta Pharma Ltd.

  • Sanofi India Ltd.

  • Pfizer Ltd.

  • Aster DM Healthcare Ltd.

  • IPCA Laboratories Ltd.

  • Alembic Ltd.

  • Narayana Hrudayalaya Ltd.

  • Gufic Biosciences Ltd.

  • TREPS

  • Sequent Scientific Ltd.

  • Glaxosmithkline Pharmaceuticals Ltd.

  • Natco Pharma Ltd.

  • Solara Active Pharma Sciences Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Shreno Ltd.

  • Net Receivable / Payable

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

View More

About SBI Healthcare Opportunities Fund

Scheme Analysis

SBI Healthcare Opportunities Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to SBI Mutual Fund. It was launched on 03-Jul-1999 and currently has an AUM of ₹926.47 crore. SBI Healthcare Opportunities Fund is benchmarked against S&P BSE Health Care as primary index and S&P BSE Health Care - TRI as primary index and S&P BSE SENSEX - TRI as secondary index.

The NAV of SBI Healthcare Opportunities Fund ended down ₹-0.13(-0.17%)yesterday to ₹78.6818.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The SBI Healthcare Opportunities Fund is managed by Tanmaya Desai .

Fund House Contact

191, Maker Tower 'E' Cuffe Parade Mumbai - 400 005

022 - 22180221-27
022 - 22189663
www.sbimf.com

Fund Manager

  • Education:B.E (Electronics),MBA (Finance),C.F.A(USA) Level III candidate
  • Experience:6 years
  • Basic Details:Mr. Desai has close to 6 years of work experience with over 3 years of experience in Indian capital markets. He has been associated with SBI Funds Management Private Limited from May 2008. Prior to join SBI Funds Management Pvt. Ltd. he was a lecturer in Electronics Department with D J Sanghvi College of Engineering, Mumbai.
  • Funds Managed:
  • SBI Healthcare Opportunities Fund

Most Recent Dividend

  • 16/03/2018

  • 30/01/2015

  • 04/01/2005

  • 06/09/2004

  • 22/09/2003

  • Cash

  • Equity

  • Preference Shares

View More